PAXMEDICA, INC.Letter Agreement • September 6th, 2023 • PaxMedica, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 6th, 2023 Company IndustryThis waiver letter agreement (this “Waiver Letter”), to the convertible promissory note, dated as of February 6, 2023 (the “Note”), by and between PaxMedica, Inc., a Delaware corporation (the “Company”) and Lind Global Fund II LP, a Delaware limited partnership (“Lind Global”), is made as of September 5, 2023. Unless otherwise indicated, capitalized terms shall have the meanings ascribed to them in the Note.